Epithelial-Mesenchymal Transition, human (Scheel, 2011)
Gene Symbol | Gene ID | Gene Info |
---|---|---|
MAFK
|
ENSG00000198517.5 | MAFK |
Gene | Promoter | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|
MAFK | hg19_v2_chr7_+_1570322_1570360 | 0.65 | 7.8e-02 | Click! |
Promoter | Score | Transcript | Gene | Gene Info |
---|---|---|---|---|
chr10_+_118187379 | 4.54 |
ENST00000369230.3 |
PNLIPRP3 |
pancreatic lipase-related protein 3 |
chr2_+_47596287 | 2.48 |
ENST00000263735.4 |
EPCAM |
epithelial cell adhesion molecule |
chr20_+_58296265 | 2.08 |
ENST00000395636.2 ENST00000361300.4 |
PHACTR3 |
phosphatase and actin regulator 3 |
chr1_+_156030937 | 1.93 |
ENST00000361084.5 |
RAB25 |
RAB25, member RAS oncogene family |
chr19_+_35609380 | 1.65 |
ENST00000604621.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr18_+_61445007 | 1.62 |
ENST00000447428.1 ENST00000546027.1 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr8_+_82644669 | 1.54 |
ENST00000297265.4 |
CHMP4C |
charged multivesicular body protein 4C |
chr19_-_36001113 | 1.46 |
ENST00000434389.1 |
DMKN |
dermokine |
chr1_+_153004800 | 1.34 |
ENST00000392661.3 |
SPRR1B |
small proline-rich protein 1B |
chr19_-_10697895 | 1.32 |
ENST00000591240.1 ENST00000589684.1 ENST00000591676.1 ENST00000250244.6 ENST00000590923.1 |
AP1M2 |
adaptor-related protein complex 1, mu 2 subunit |
chr6_+_125540951 | 1.31 |
ENST00000524679.1 |
TPD52L1 |
tumor protein D52-like 1 |
chr4_-_110723134 | 1.28 |
ENST00000510800.1 ENST00000512148.1 |
CFI |
complement factor I |
chr10_-_116444371 | 1.24 |
ENST00000533213.2 ENST00000369252.4 |
ABLIM1 |
actin binding LIM protein 1 |
chr18_+_61254534 | 1.15 |
ENST00000269489.5 |
SERPINB13 |
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr5_+_140220769 | 1.14 |
ENST00000531613.1 ENST00000378123.3 |
PCDHA8 |
protocadherin alpha 8 |
chr6_-_47010061 | 1.11 |
ENST00000371253.2 |
GPR110 |
G protein-coupled receptor 110 |
chr18_+_61254570 | 1.11 |
ENST00000344731.5 |
SERPINB13 |
serpin peptidase inhibitor, clade B (ovalbumin), member 13 |
chr18_+_61554932 | 1.07 |
ENST00000299502.4 ENST00000457692.1 ENST00000413956.1 |
SERPINB2 |
serpin peptidase inhibitor, clade B (ovalbumin), member 2 |
chr6_+_125524785 | 1.05 |
ENST00000392482.2 |
TPD52L1 |
tumor protein D52-like 1 |
chr10_+_47746929 | 1.03 |
ENST00000340243.6 ENST00000374277.5 ENST00000449464.2 ENST00000538825.1 ENST00000335083.5 |
ANXA8L2 AL603965.1 |
annexin A8-like 2 Protein LOC100996760 |
chr10_-_10836919 | 1.00 |
ENST00000602763.1 ENST00000415590.2 ENST00000434919.2 |
SFTA1P |
surfactant associated 1, pseudogene |
chr4_-_90756769 | 1.00 |
ENST00000345009.4 ENST00000505199.1 ENST00000502987.1 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr3_-_151034734 | 0.99 |
ENST00000260843.4 |
GPR87 |
G protein-coupled receptor 87 |
chr5_+_140213815 | 0.97 |
ENST00000525929.1 ENST00000378125.3 |
PCDHA7 |
protocadherin alpha 7 |
chr1_-_153113927 | 0.95 |
ENST00000368752.4 |
SPRR2B |
small proline-rich protein 2B |
chr4_-_110723194 | 0.94 |
ENST00000394635.3 |
CFI |
complement factor I |
chr3_+_122044084 | 0.93 |
ENST00000264474.3 ENST00000479204.1 |
CSTA |
cystatin A (stefin A) |
chr5_+_140207536 | 0.93 |
ENST00000529310.1 ENST00000527624.1 |
PCDHA6 |
protocadherin alpha 6 |
chr1_+_15256230 | 0.93 |
ENST00000376028.4 ENST00000400798.2 |
KAZN |
kazrin, periplakin interacting protein |
chr22_+_32455111 | 0.93 |
ENST00000543737.1 |
SLC5A1 |
solute carrier family 5 (sodium/glucose cotransporter), member 1 |
chr17_-_7167279 | 0.91 |
ENST00000571932.2 |
CLDN7 |
claudin 7 |
chr6_+_90272027 | 0.91 |
ENST00000522441.1 |
ANKRD6 |
ankyrin repeat domain 6 |
chr6_-_11779014 | 0.86 |
ENST00000229583.5 |
ADTRP |
androgen-dependent TFPI-regulating protein |
chr8_+_24772455 | 0.84 |
ENST00000433454.2 |
NEFM |
neurofilament, medium polypeptide |
chr14_-_51562745 | 0.84 |
ENST00000298355.3 |
TRIM9 |
tripartite motif containing 9 |
chr4_+_41540160 | 0.83 |
ENST00000503057.1 ENST00000511496.1 |
LIMCH1 |
LIM and calponin homology domains 1 |
chr6_-_11779174 | 0.82 |
ENST00000379413.2 |
ADTRP |
androgen-dependent TFPI-regulating protein |
chr19_+_35607166 | 0.82 |
ENST00000604255.1 ENST00000346446.5 ENST00000344013.6 ENST00000603449.1 ENST00000406988.1 ENST00000605550.1 ENST00000604804.1 ENST00000605552.1 |
FXYD3 |
FXYD domain containing ion transport regulator 3 |
chr6_-_11779840 | 0.82 |
ENST00000506810.1 |
ADTRP |
androgen-dependent TFPI-regulating protein |
chr4_-_110723335 | 0.82 |
ENST00000394634.2 |
CFI |
complement factor I |
chr3_-_190167571 | 0.82 |
ENST00000354905.2 |
TMEM207 |
transmembrane protein 207 |
chr3_-_111314230 | 0.81 |
ENST00000317012.4 |
ZBED2 |
zinc finger, BED-type containing 2 |
chr6_+_36097992 | 0.81 |
ENST00000211287.4 |
MAPK13 |
mitogen-activated protein kinase 13 |
chr12_+_113344755 | 0.80 |
ENST00000550883.1 |
OAS1 |
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr4_-_90757364 | 0.80 |
ENST00000508895.1 |
SNCA |
synuclein, alpha (non A4 component of amyloid precursor) |
chr1_+_26856236 | 0.80 |
ENST00000374168.2 ENST00000374166.4 |
RPS6KA1 |
ribosomal protein S6 kinase, 90kDa, polypeptide 1 |
chr7_-_142139783 | 0.79 |
ENST00000390374.3 |
TRBV7-6 |
T cell receptor beta variable 7-6 |
chr12_+_20968608 | 0.79 |
ENST00000381541.3 ENST00000540229.1 ENST00000553473.1 ENST00000554957.1 |
LST3 SLCO1B3 SLCO1B7 |
Putative solute carrier organic anion transporter family member 1B7; Uncharacterized protein solute carrier organic anion transporter family, member 1B3 solute carrier organic anion transporter family, member 1B7 (non-functional) |
chr8_-_38008783 | 0.79 |
ENST00000276449.4 |
STAR |
steroidogenic acute regulatory protein |
chr7_-_16840820 | 0.78 |
ENST00000450569.1 |
AGR2 |
anterior gradient 2 |
chr6_+_116782527 | 0.78 |
ENST00000368606.3 ENST00000368605.1 |
FAM26F |
family with sequence similarity 26, member F |
chr6_-_52628271 | 0.77 |
ENST00000493422.1 |
GSTA2 |
glutathione S-transferase alpha 2 |
chr6_+_27215471 | 0.76 |
ENST00000421826.2 |
PRSS16 |
protease, serine, 16 (thymus) |
chr18_+_61442629 | 0.75 |
ENST00000398019.2 ENST00000540675.1 |
SERPINB7 |
serpin peptidase inhibitor, clade B (ovalbumin), member 7 |
chr9_-_5833027 | 0.75 |
ENST00000339450.5 |
ERMP1 |
endoplasmic reticulum metallopeptidase 1 |
chr1_+_233765353 | 0.75 |
ENST00000366620.1 |
KCNK1 |
potassium channel, subfamily K, member 1 |
chr1_-_117210290 | 0.74 |
ENST00000369483.1 ENST00000369486.3 |
IGSF3 |
immunoglobulin superfamily, member 3 |
chr9_+_12693336 | 0.73 |
ENST00000381137.2 ENST00000388918.5 |
TYRP1 |
tyrosinase-related protein 1 |
chr10_-_135379132 | 0.71 |
ENST00000343131.5 |
SYCE1 |
synaptonemal complex central element protein 1 |
chr4_-_74486217 | 0.71 |
ENST00000335049.5 ENST00000307439.5 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr3_+_113666748 | 0.71 |
ENST00000330212.3 ENST00000498275.1 |
ZDHHC23 |
zinc finger, DHHC-type containing 23 |
chr1_+_186798073 | 0.70 |
ENST00000367466.3 ENST00000442353.2 |
PLA2G4A |
phospholipase A2, group IVA (cytosolic, calcium-dependent) |
chr12_+_113354341 | 0.67 |
ENST00000553152.1 |
OAS1 |
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chrX_-_24690771 | 0.67 |
ENST00000379145.1 |
PCYT1B |
phosphate cytidylyltransferase 1, choline, beta |
chr20_+_58630972 | 0.66 |
ENST00000313426.1 |
C20orf197 |
chromosome 20 open reading frame 197 |
chr7_-_20256965 | 0.66 |
ENST00000400331.5 ENST00000332878.4 |
MACC1 |
metastasis associated in colon cancer 1 |
chrX_+_41548259 | 0.65 |
ENST00000378138.5 |
GPR34 |
G protein-coupled receptor 34 |
chr7_-_16921601 | 0.65 |
ENST00000402239.3 ENST00000310398.2 ENST00000414935.1 |
AGR3 |
anterior gradient 3 |
chr17_-_39780819 | 0.64 |
ENST00000311208.8 |
KRT17 |
keratin 17 |
chr21_+_43919710 | 0.63 |
ENST00000398341.3 |
SLC37A1 |
solute carrier family 37 (glucose-6-phosphate transporter), member 1 |
chr3_+_189507523 | 0.63 |
ENST00000437221.1 ENST00000392463.2 ENST00000392461.3 ENST00000449992.1 ENST00000456148.1 |
TP63 |
tumor protein p63 |
chr11_+_6866883 | 0.63 |
ENST00000299454.4 ENST00000379831.2 |
OR10A5 |
olfactory receptor, family 10, subfamily A, member 5 |
chr11_-_125648690 | 0.62 |
ENST00000436890.2 ENST00000358524.3 |
PATE2 |
prostate and testis expressed 2 |
chr12_+_113344811 | 0.62 |
ENST00000551241.1 ENST00000553185.1 ENST00000550689.1 |
OAS1 |
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr5_+_140235469 | 0.62 |
ENST00000506939.2 ENST00000307360.5 |
PCDHA10 |
protocadherin alpha 10 |
chr6_+_27215494 | 0.61 |
ENST00000230582.3 |
PRSS16 |
protease, serine, 16 (thymus) |
chr12_+_29376673 | 0.61 |
ENST00000547116.1 |
FAR2 |
fatty acyl CoA reductase 2 |
chr1_+_47533160 | 0.61 |
ENST00000334194.3 |
CYP4Z1 |
cytochrome P450, family 4, subfamily Z, polypeptide 1 |
chr11_-_2924970 | 0.61 |
ENST00000533594.1 |
SLC22A18AS |
solute carrier family 22 (organic cation transporter), member 18 antisense |
chr12_+_29376592 | 0.61 |
ENST00000182377.4 |
FAR2 |
fatty acyl CoA reductase 2 |
chr7_-_71877318 | 0.60 |
ENST00000395275.2 |
CALN1 |
calneuron 1 |
chr18_-_61329118 | 0.59 |
ENST00000332821.8 ENST00000283752.5 |
SERPINB3 |
serpin peptidase inhibitor, clade B (ovalbumin), member 3 |
chr7_+_16793160 | 0.59 |
ENST00000262067.4 |
TSPAN13 |
tetraspanin 13 |
chr1_-_153013588 | 0.58 |
ENST00000360379.3 |
SPRR2D |
small proline-rich protein 2D |
chr17_-_54893250 | 0.58 |
ENST00000397862.2 |
C17orf67 |
chromosome 17 open reading frame 67 |
chr11_-_114466477 | 0.57 |
ENST00000375478.3 |
NXPE4 |
neurexophilin and PC-esterase domain family, member 4 |
chr8_+_94241867 | 0.57 |
ENST00000598428.1 |
AC016885.1 |
Uncharacterized protein |
chr11_-_66139199 | 0.57 |
ENST00000357440.2 |
SLC29A2 |
solute carrier family 29 (equilibrative nucleoside transporter), member 2 |
chr8_+_18248786 | 0.57 |
ENST00000520116.1 |
NAT2 |
N-acetyltransferase 2 (arylamine N-acetyltransferase) |
chr6_-_47009996 | 0.57 |
ENST00000371243.2 |
GPR110 |
G protein-coupled receptor 110 |
chr14_+_94640633 | 0.57 |
ENST00000304338.3 |
PPP4R4 |
protein phosphatase 4, regulatory subunit 4 |
chr12_+_115800817 | 0.56 |
ENST00000547948.1 |
RP11-116D17.1 |
HCG2038717; Uncharacterized protein |
chr3_-_121379739 | 0.56 |
ENST00000428394.2 ENST00000314583.3 |
HCLS1 |
hematopoietic cell-specific Lyn substrate 1 |
chr6_-_155776966 | 0.56 |
ENST00000159060.2 |
NOX3 |
NADPH oxidase 3 |
chr19_+_15160130 | 0.56 |
ENST00000427043.3 |
CASP14 |
caspase 14, apoptosis-related cysteine peptidase |
chr19_-_44324750 | 0.55 |
ENST00000594049.1 ENST00000414615.2 |
LYPD5 |
LY6/PLAUR domain containing 5 |
chr2_+_191002486 | 0.55 |
ENST00000396974.2 |
C2orf88 |
chromosome 2 open reading frame 88 |
chr13_-_44735393 | 0.55 |
ENST00000400419.1 |
SMIM2 |
small integral membrane protein 2 |
chr19_+_20959098 | 0.54 |
ENST00000360204.5 ENST00000594534.1 |
ZNF66 |
zinc finger protein 66 |
chr3_+_111717511 | 0.54 |
ENST00000478951.1 ENST00000393917.2 |
TAGLN3 |
transgelin 3 |
chr8_-_102218292 | 0.54 |
ENST00000518336.1 ENST00000520454.1 |
ZNF706 |
zinc finger protein 706 |
chr1_+_70876926 | 0.53 |
ENST00000370938.3 ENST00000346806.2 |
CTH |
cystathionase (cystathionine gamma-lyase) |
chr17_+_39394250 | 0.53 |
ENST00000254072.6 |
KRTAP9-8 |
keratin associated protein 9-8 |
chr6_-_32784687 | 0.52 |
ENST00000447394.1 ENST00000438763.2 |
HLA-DOB |
major histocompatibility complex, class II, DO beta |
chr11_+_18154059 | 0.52 |
ENST00000531264.1 |
MRGPRX3 |
MAS-related GPR, member X3 |
chr5_-_74162605 | 0.52 |
ENST00000389156.4 ENST00000510496.1 ENST00000380515.3 |
FAM169A |
family with sequence similarity 169, member A |
chr8_-_91095099 | 0.52 |
ENST00000265431.3 |
CALB1 |
calbindin 1, 28kDa |
chr20_-_50722183 | 0.51 |
ENST00000371523.4 |
ZFP64 |
ZFP64 zinc finger protein |
chr5_+_140227048 | 0.51 |
ENST00000532602.1 |
PCDHA9 |
protocadherin alpha 9 |
chr3_+_183967409 | 0.51 |
ENST00000324557.4 ENST00000402825.3 |
ECE2 |
endothelin converting enzyme 2 |
chr1_-_216978709 | 0.50 |
ENST00000360012.3 |
ESRRG |
estrogen-related receptor gamma |
chr12_+_70219052 | 0.50 |
ENST00000552032.2 ENST00000547771.2 |
MYRFL |
myelin regulatory factor-like |
chr18_+_616672 | 0.50 |
ENST00000338387.7 |
CLUL1 |
clusterin-like 1 (retinal) |
chr2_-_8464760 | 0.50 |
ENST00000430192.1 |
LINC00299 |
long intergenic non-protein coding RNA 299 |
chr11_+_10476851 | 0.49 |
ENST00000396553.2 |
AMPD3 |
adenosine monophosphate deaminase 3 |
chr5_-_74326724 | 0.49 |
ENST00000322348.4 |
GCNT4 |
glucosaminyl (N-acetyl) transferase 4, core 2 |
chr4_-_159956333 | 0.49 |
ENST00000434826.2 |
C4orf45 |
chromosome 4 open reading frame 45 |
chr10_+_24497704 | 0.48 |
ENST00000376456.4 ENST00000458595.1 |
KIAA1217 |
KIAA1217 |
chr8_+_1993152 | 0.48 |
ENST00000262113.4 |
MYOM2 |
myomesin 2 |
chr1_+_172389821 | 0.48 |
ENST00000367727.4 |
C1orf105 |
chromosome 1 open reading frame 105 |
chr3_+_98482175 | 0.48 |
ENST00000485391.1 ENST00000492254.1 |
ST3GAL6 |
ST3 beta-galactoside alpha-2,3-sialyltransferase 6 |
chr11_-_104972158 | 0.48 |
ENST00000598974.1 ENST00000593315.1 ENST00000594519.1 ENST00000415981.2 ENST00000525374.1 ENST00000375707.1 |
CASP1 CARD16 CARD17 |
caspase 1, apoptosis-related cysteine peptidase caspase recruitment domain family, member 16 caspase recruitment domain family, member 17 |
chr5_-_134914673 | 0.47 |
ENST00000512158.1 |
CXCL14 |
chemokine (C-X-C motif) ligand 14 |
chr1_-_207095324 | 0.47 |
ENST00000530505.1 ENST00000367091.3 ENST00000442471.2 |
FAIM3 |
Fas apoptotic inhibitory molecule 3 |
chr18_-_29340827 | 0.47 |
ENST00000269205.5 |
SLC25A52 |
solute carrier family 25, member 52 |
chr11_+_57365150 | 0.47 |
ENST00000457869.1 ENST00000340687.6 ENST00000378323.4 ENST00000378324.2 ENST00000403558.1 |
SERPING1 |
serpin peptidase inhibitor, clade G (C1 inhibitor), member 1 |
chr1_+_196857144 | 0.47 |
ENST00000367416.2 ENST00000251424.4 ENST00000367418.2 |
CFHR4 |
complement factor H-related 4 |
chr2_+_89890533 | 0.47 |
ENST00000429992.2 |
IGKV2D-40 |
immunoglobulin kappa variable 2D-40 |
chr18_+_616711 | 0.47 |
ENST00000579494.1 |
CLUL1 |
clusterin-like 1 (retinal) |
chr11_-_2924720 | 0.46 |
ENST00000455942.2 |
SLC22A18AS |
solute carrier family 22 (organic cation transporter), member 18 antisense |
chr2_-_89459813 | 0.46 |
ENST00000390256.2 |
IGKV6-21 |
immunoglobulin kappa variable 6-21 (non-functional) |
chr14_+_21387508 | 0.46 |
ENST00000555624.1 |
RP11-84C10.2 |
RP11-84C10.2 |
chr1_+_81771806 | 0.46 |
ENST00000370721.1 ENST00000370727.1 ENST00000370725.1 ENST00000370723.1 ENST00000370728.1 ENST00000370730.1 |
LPHN2 |
latrophilin 2 |
chr17_-_76124711 | 0.46 |
ENST00000306591.7 ENST00000590602.1 |
TMC6 |
transmembrane channel-like 6 |
chr6_+_33043703 | 0.45 |
ENST00000418931.2 ENST00000535465.1 |
HLA-DPB1 |
major histocompatibility complex, class II, DP beta 1 |
chr1_-_12677714 | 0.45 |
ENST00000376223.2 |
DHRS3 |
dehydrogenase/reductase (SDR family) member 3 |
chr6_-_107235287 | 0.45 |
ENST00000436659.1 ENST00000428750.1 ENST00000427903.1 |
RP1-60O19.1 |
RP1-60O19.1 |
chr12_+_21207503 | 0.45 |
ENST00000545916.1 |
SLCO1B7 |
solute carrier organic anion transporter family, member 1B7 (non-functional) |
chr6_-_25874440 | 0.45 |
ENST00000361703.6 ENST00000397060.4 |
SLC17A3 |
solute carrier family 17 (organic anion transporter), member 3 |
chr19_+_41281416 | 0.45 |
ENST00000597140.1 |
MIA |
melanoma inhibitory activity |
chr18_-_74839891 | 0.44 |
ENST00000581878.1 |
MBP |
myelin basic protein |
chr1_+_84873913 | 0.44 |
ENST00000370662.3 |
DNASE2B |
deoxyribonuclease II beta |
chr2_+_103353367 | 0.43 |
ENST00000454536.1 ENST00000409528.1 ENST00000409173.1 |
TMEM182 |
transmembrane protein 182 |
chr6_+_121756809 | 0.43 |
ENST00000282561.3 |
GJA1 |
gap junction protein, alpha 1, 43kDa |
chrX_+_135614293 | 0.42 |
ENST00000370634.3 |
VGLL1 |
vestigial like 1 (Drosophila) |
chr8_+_101170563 | 0.42 |
ENST00000520508.1 ENST00000388798.2 |
SPAG1 |
sperm associated antigen 1 |
chr4_-_143227088 | 0.42 |
ENST00000511838.1 |
INPP4B |
inositol polyphosphate-4-phosphatase, type II, 105kDa |
chr20_-_60573188 | 0.41 |
ENST00000474089.1 |
TAF4 |
TAF4 RNA polymerase II, TATA box binding protein (TBP)-associated factor, 135kDa |
chr11_-_58980342 | 0.41 |
ENST00000361050.3 |
MPEG1 |
macrophage expressed 1 |
chr8_+_32579341 | 0.41 |
ENST00000519240.1 ENST00000539990.1 |
NRG1 |
neuregulin 1 |
chr14_-_92333873 | 0.41 |
ENST00000435962.2 |
TC2N |
tandem C2 domains, nuclear |
chr1_+_196743912 | 0.41 |
ENST00000367425.4 |
CFHR3 |
complement factor H-related 3 |
chr5_+_66300446 | 0.41 |
ENST00000261569.7 |
MAST4 |
microtubule associated serine/threonine kinase family member 4 |
chr4_+_100432161 | 0.41 |
ENST00000326581.4 ENST00000514652.1 |
C4orf17 |
chromosome 4 open reading frame 17 |
chr4_-_48082192 | 0.41 |
ENST00000507351.1 |
TXK |
TXK tyrosine kinase |
chr21_-_42219065 | 0.40 |
ENST00000400454.1 |
DSCAM |
Down syndrome cell adhesion molecule |
chr11_+_60163775 | 0.40 |
ENST00000300187.6 ENST00000395005.2 |
MS4A14 |
membrane-spanning 4-domains, subfamily A, member 14 |
chr7_+_139528952 | 0.40 |
ENST00000416849.2 ENST00000436047.2 ENST00000414508.2 ENST00000448866.1 |
TBXAS1 |
thromboxane A synthase 1 (platelet) |
chr2_-_74669009 | 0.40 |
ENST00000272430.5 |
RTKN |
rhotekin |
chr3_-_112693865 | 0.40 |
ENST00000471858.1 ENST00000295863.4 ENST00000308611.3 |
CD200R1 |
CD200 receptor 1 |
chr11_-_102668879 | 0.40 |
ENST00000315274.6 |
MMP1 |
matrix metallopeptidase 1 (interstitial collagenase) |
chr4_-_170924888 | 0.40 |
ENST00000502832.1 ENST00000393704.3 |
MFAP3L |
microfibrillar-associated protein 3-like |
chr8_+_103563792 | 0.40 |
ENST00000285402.3 |
ODF1 |
outer dense fiber of sperm tails 1 |
chr18_-_61311485 | 0.40 |
ENST00000436264.1 ENST00000356424.6 ENST00000341074.5 |
SERPINB4 |
serpin peptidase inhibitor, clade B (ovalbumin), member 4 |
chr17_-_76124812 | 0.40 |
ENST00000592063.1 ENST00000589271.1 ENST00000322933.4 ENST00000589553.1 |
TMC6 |
transmembrane channel-like 6 |
chr9_+_125281420 | 0.39 |
ENST00000340750.1 |
OR1J4 |
olfactory receptor, family 1, subfamily J, member 4 |
chr5_-_16509101 | 0.39 |
ENST00000399793.2 |
FAM134B |
family with sequence similarity 134, member B |
chr2_-_89327228 | 0.39 |
ENST00000483158.1 |
IGKV3-11 |
immunoglobulin kappa variable 3-11 |
chr11_+_27076764 | 0.39 |
ENST00000525090.1 |
BBOX1 |
butyrobetaine (gamma), 2-oxoglutarate dioxygenase (gamma-butyrobetaine hydroxylase) 1 |
chr6_+_26251835 | 0.39 |
ENST00000356350.2 |
HIST1H2BH |
histone cluster 1, H2bh |
chr4_+_95972822 | 0.39 |
ENST00000509540.1 ENST00000440890.2 |
BMPR1B |
bone morphogenetic protein receptor, type IB |
chr9_-_104249319 | 0.38 |
ENST00000374847.1 |
TMEM246 |
transmembrane protein 246 |
chr2_+_203499901 | 0.38 |
ENST00000303116.6 ENST00000392238.2 |
FAM117B |
family with sequence similarity 117, member B |
chr7_+_139529040 | 0.38 |
ENST00000455353.1 ENST00000458722.1 ENST00000411653.1 |
TBXAS1 |
thromboxane A synthase 1 (platelet) |
chr2_+_1418154 | 0.38 |
ENST00000423320.1 ENST00000382198.1 |
TPO |
thyroid peroxidase |
chr17_+_57297807 | 0.38 |
ENST00000284116.4 ENST00000581140.1 ENST00000581276.1 |
GDPD1 |
glycerophosphodiester phosphodiesterase domain containing 1 |
chr20_-_18774614 | 0.38 |
ENST00000412553.1 |
LINC00652 |
long intergenic non-protein coding RNA 652 |
chr1_-_153044083 | 0.38 |
ENST00000341611.2 |
SPRR2B |
small proline-rich protein 2B |
chr5_+_55147205 | 0.38 |
ENST00000396836.2 ENST00000396834.1 ENST00000447346.2 ENST00000359040.5 |
IL31RA |
interleukin 31 receptor A |
chr1_-_226926864 | 0.38 |
ENST00000429204.1 ENST00000366784.1 |
ITPKB |
inositol-trisphosphate 3-kinase B |
chr16_+_82068830 | 0.38 |
ENST00000199936.4 |
HSD17B2 |
hydroxysteroid (17-beta) dehydrogenase 2 |
chr4_-_74486347 | 0.38 |
ENST00000342081.3 |
RASSF6 |
Ras association (RalGDS/AF-6) domain family member 6 |
chr2_+_90211643 | 0.38 |
ENST00000390277.2 |
IGKV3D-11 |
immunoglobulin kappa variable 3D-11 |
chr7_-_56101826 | 0.37 |
ENST00000421626.1 |
PSPH |
phosphoserine phosphatase |
chr17_+_41476327 | 0.37 |
ENST00000320033.4 |
ARL4D |
ADP-ribosylation factor-like 4D |
chr6_-_134373732 | 0.37 |
ENST00000275230.5 |
SLC2A12 |
solute carrier family 2 (facilitated glucose transporter), member 12 |
chr5_+_54398463 | 0.37 |
ENST00000274306.6 |
GZMA |
granzyme A (granzyme 1, cytotoxic T-lymphocyte-associated serine esterase 3) |
chr6_+_26199737 | 0.37 |
ENST00000359985.1 |
HIST1H2BF |
histone cluster 1, H2bf |
chr8_+_1993173 | 0.37 |
ENST00000523438.1 |
MYOM2 |
myomesin 2 |
chr12_-_87232644 | 0.37 |
ENST00000549405.2 |
MGAT4C |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr18_-_67873078 | 0.37 |
ENST00000255674.6 |
RTTN |
rotatin |
chr12_-_86650045 | 0.37 |
ENST00000604798.1 |
MGAT4C |
mannosyl (alpha-1,3-)-glycoprotein beta-1,4-N-acetylglucosaminyltransferase, isozyme C (putative) |
chr12_+_113344582 | 0.36 |
ENST00000202917.5 ENST00000445409.2 ENST00000452357.2 |
OAS1 |
2'-5'-oligoadenylate synthetase 1, 40/46kDa |
chr3_+_111260954 | 0.36 |
ENST00000283285.5 |
CD96 |
CD96 molecule |
chrX_+_138612889 | 0.36 |
ENST00000218099.2 ENST00000394090.2 |
F9 |
coagulation factor IX |
chr19_-_42894420 | 0.36 |
ENST00000597255.1 ENST00000222032.5 |
CNFN |
cornifelin |
chr18_-_52989525 | 0.36 |
ENST00000457482.3 |
TCF4 |
transcription factor 4 |
chrX_+_41548220 | 0.36 |
ENST00000378142.4 |
GPR34 |
G protein-coupled receptor 34 |
chr19_-_43099070 | 0.36 |
ENST00000244336.5 |
CEACAM8 |
carcinoembryonic antigen-related cell adhesion molecule 8 |
chr5_-_35938674 | 0.36 |
ENST00000397366.1 ENST00000513623.1 ENST00000514524.1 ENST00000397367.2 |
CAPSL |
calcyphosine-like |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.6 | 2.4 | GO:0090362 | positive regulation of platelet-derived growth factor production(GO:0090362) |
0.4 | 2.5 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
0.4 | 1.8 | GO:0032227 | negative regulation of synaptic transmission, dopaminergic(GO:0032227) negative regulation of dopamine uptake involved in synaptic transmission(GO:0051585) norepinephrine uptake(GO:0051620) regulation of norepinephrine uptake(GO:0051621) negative regulation of norepinephrine uptake(GO:0051622) negative regulation of catecholamine uptake involved in synaptic transmission(GO:0051945) regulation of glutathione peroxidase activity(GO:1903282) positive regulation of glutathione peroxidase activity(GO:1903284) positive regulation of hydrogen peroxide catabolic process(GO:1903285) positive regulation of peroxidase activity(GO:2000470) |
0.3 | 1.5 | GO:0090611 | ubiquitin-independent protein catabolic process via the multivesicular body sorting pathway(GO:0090611) |
0.3 | 0.8 | GO:0033693 | neurofilament bundle assembly(GO:0033693) |
0.3 | 0.8 | GO:0035544 | negative regulation of SNARE complex assembly(GO:0035544) |
0.3 | 0.8 | GO:0018894 | dibenzo-p-dioxin metabolic process(GO:0018894) positive regulation of bile acid biosynthetic process(GO:0070859) positive regulation of bile acid metabolic process(GO:1904253) |
0.3 | 0.8 | GO:0002728 | negative regulation of natural killer cell cytokine production(GO:0002728) |
0.2 | 1.5 | GO:1903575 | cornified envelope assembly(GO:1903575) |
0.2 | 1.2 | GO:0010025 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.2 | 2.3 | GO:1902172 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 1.3 | GO:0009753 | response to jasmonic acid(GO:0009753) cellular response to jasmonic acid stimulus(GO:0071395) |
0.2 | 0.7 | GO:0006663 | platelet activating factor biosynthetic process(GO:0006663) |
0.2 | 0.5 | GO:0002581 | negative regulation of antigen processing and presentation of peptide or polysaccharide antigen via MHC class II(GO:0002581) |
0.2 | 0.2 | GO:0030185 | nitric oxide transport(GO:0030185) |
0.2 | 0.6 | GO:0007499 | ectoderm and mesoderm interaction(GO:0007499) |
0.1 | 0.6 | GO:0035425 | autocrine signaling(GO:0035425) |
0.1 | 0.6 | GO:0018352 | protein-pyridoxal-5-phosphate linkage(GO:0018352) |
0.1 | 0.4 | GO:0010645 | regulation of cell communication by chemical coupling(GO:0010645) positive regulation of cell communication by chemical coupling(GO:0010652) |
0.1 | 1.0 | GO:1903899 | positive regulation of PERK-mediated unfolded protein response(GO:1903899) |
0.1 | 0.5 | GO:0072344 | rescue of stalled ribosome(GO:0072344) |
0.1 | 0.9 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.1 | 0.4 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
0.1 | 0.6 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
0.1 | 0.5 | GO:0050717 | positive regulation of interleukin-1 alpha secretion(GO:0050717) |
0.1 | 0.6 | GO:0001550 | ovarian cumulus expansion(GO:0001550) fused antrum stage(GO:0048165) |
0.1 | 0.8 | GO:2000491 | positive regulation of hepatic stellate cell activation(GO:2000491) |
0.1 | 0.3 | GO:1901860 | positive regulation of mitochondrial DNA metabolic process(GO:1901860) |
0.1 | 0.3 | GO:0002325 | natural killer cell differentiation involved in immune response(GO:0002325) negative regulation of natural killer cell differentiation(GO:0032824) regulation of natural killer cell differentiation involved in immune response(GO:0032826) negative regulation of natural killer cell differentiation involved in immune response(GO:0032827) positive regulation of cytolysis in other organism(GO:0051714) |
0.1 | 0.3 | GO:1903033 | regulation of microtubule plus-end binding(GO:1903031) positive regulation of microtubule plus-end binding(GO:1903033) |
0.1 | 0.2 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.1 | 0.5 | GO:0070980 | biphenyl catabolic process(GO:0070980) |
0.1 | 0.3 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.1 | 0.3 | GO:0016561 | protein import into peroxisome matrix, translocation(GO:0016561) |
0.1 | 0.3 | GO:1904719 | excitatory chemical synaptic transmission(GO:0098976) regulation of AMPA glutamate receptor clustering(GO:1904717) positive regulation of AMPA glutamate receptor clustering(GO:1904719) |
0.1 | 1.1 | GO:0015712 | hexose phosphate transport(GO:0015712) glucose-6-phosphate transport(GO:0015760) |
0.1 | 0.8 | GO:0002074 | extraocular skeletal muscle development(GO:0002074) |
0.1 | 0.3 | GO:0060584 | detection of peptidoglycan(GO:0032499) activation of MAPK activity involved in innate immune response(GO:0035419) regulation of prostaglandin-endoperoxide synthase activity(GO:0060584) positive regulation of prostaglandin-endoperoxide synthase activity(GO:0060585) |
0.1 | 1.9 | GO:0031268 | pseudopodium organization(GO:0031268) |
0.1 | 0.3 | GO:0044034 | negative stranded viral RNA replication(GO:0039689) multi-organism biosynthetic process(GO:0044034) |
0.1 | 0.1 | GO:0051204 | protein insertion into mitochondrial membrane(GO:0051204) |
0.1 | 0.2 | GO:0051685 | maintenance of ER location(GO:0051685) |
0.1 | 0.5 | GO:0006196 | AMP catabolic process(GO:0006196) |
0.1 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.1 | 2.0 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
0.1 | 0.2 | GO:2000863 | positive regulation of estrogen secretion(GO:2000863) positive regulation of estradiol secretion(GO:2000866) |
0.1 | 0.5 | GO:0035633 | maintenance of blood-brain barrier(GO:0035633) regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904207) positive regulation of chemokine (C-C motif) ligand 2 secretion(GO:1904209) |
0.1 | 0.2 | GO:0006422 | aspartyl-tRNA aminoacylation(GO:0006422) |
0.1 | 0.4 | GO:0060332 | positive regulation of response to interferon-gamma(GO:0060332) positive regulation of interferon-gamma-mediated signaling pathway(GO:0060335) |
0.1 | 0.4 | GO:0018343 | protein farnesylation(GO:0018343) |
0.1 | 0.2 | GO:2001226 | negative regulation of chloride transport(GO:2001226) |
0.1 | 0.6 | GO:0052696 | flavonoid glucuronidation(GO:0052696) xenobiotic glucuronidation(GO:0052697) |
0.1 | 0.6 | GO:0035502 | metanephric part of ureteric bud development(GO:0035502) |
0.1 | 0.8 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
0.1 | 0.8 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.1 | 0.5 | GO:2000503 | positive regulation of natural killer cell chemotaxis(GO:2000503) |
0.1 | 0.4 | GO:0032185 | septin cytoskeleton organization(GO:0032185) |
0.1 | 0.9 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
0.1 | 0.2 | GO:0030264 | nuclear fragmentation involved in apoptotic nuclear change(GO:0030264) |
0.1 | 0.6 | GO:0048840 | otolith development(GO:0048840) |
0.1 | 0.7 | GO:0032808 | lacrimal gland development(GO:0032808) |
0.1 | 0.7 | GO:0006657 | CDP-choline pathway(GO:0006657) |
0.1 | 0.2 | GO:0010430 | fatty acid omega-oxidation(GO:0010430) |
0.1 | 0.2 | GO:0019836 | hemolysis by symbiont of host erythrocytes(GO:0019836) hemolysis in other organism(GO:0044179) hemolysis in other organism involved in symbiotic interaction(GO:0052331) |
0.1 | 0.3 | GO:1902202 | regulation of hepatocyte growth factor receptor signaling pathway(GO:1902202) |
0.1 | 0.4 | GO:0021840 | directional guidance of interneurons involved in migration from the subpallium to the cortex(GO:0021840) chemorepulsion involved in interneuron migration from the subpallium to the cortex(GO:0021842) |
0.1 | 0.3 | GO:0033078 | extrathymic T cell differentiation(GO:0033078) |
0.1 | 0.2 | GO:0042214 | terpene metabolic process(GO:0042214) |
0.1 | 0.4 | GO:0035995 | detection of muscle stretch(GO:0035995) |
0.1 | 0.2 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
0.1 | 0.6 | GO:0071688 | striated muscle myosin thick filament assembly(GO:0071688) |
0.1 | 0.2 | GO:0010585 | glutamine secretion(GO:0010585) L-glutamine import(GO:0036229) L-glutamine import into cell(GO:1903803) |
0.1 | 0.2 | GO:0003350 | pulmonary myocardium development(GO:0003350) |
0.1 | 0.2 | GO:0060373 | regulation of ventricular cardiac muscle cell membrane depolarization(GO:0060373) |
0.1 | 1.0 | GO:0035745 | T-helper 2 cell cytokine production(GO:0035745) |
0.1 | 0.2 | GO:0035378 | carbon dioxide transmembrane transport(GO:0035378) |
0.1 | 0.2 | GO:0089712 | L-aspartate transport(GO:0070778) L-aspartate transmembrane transport(GO:0089712) |
0.1 | 0.1 | GO:0045824 | negative regulation of innate immune response(GO:0045824) |
0.1 | 0.5 | GO:0002118 | aggressive behavior(GO:0002118) |
0.0 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.0 | 0.1 | GO:0018315 | molybdenum incorporation into molybdenum-molybdopterin complex(GO:0018315) metal incorporation into metallo-molybdopterin complex(GO:0042040) glycine receptor clustering(GO:0072579) |
0.0 | 0.4 | GO:0052695 | cellular glucuronidation(GO:0052695) |
0.0 | 0.1 | GO:0070637 | nicotinamide riboside catabolic process(GO:0006738) nicotinamide riboside metabolic process(GO:0046495) pyridine nucleoside metabolic process(GO:0070637) pyridine nucleoside catabolic process(GO:0070638) |
0.0 | 6.7 | GO:0070268 | cornification(GO:0070268) |
0.0 | 0.4 | GO:0033029 | regulation of neutrophil apoptotic process(GO:0033029) common myeloid progenitor cell proliferation(GO:0035726) |
0.0 | 0.3 | GO:0070257 | hepoxilin metabolic process(GO:0051121) hepoxilin biosynthetic process(GO:0051122) positive regulation of mucus secretion(GO:0070257) |
0.0 | 0.3 | GO:1990481 | mRNA pseudouridine synthesis(GO:1990481) |
0.0 | 0.1 | GO:0097254 | renal tubular secretion(GO:0097254) |
0.0 | 0.1 | GO:0072709 | cellular response to sorbitol(GO:0072709) |
0.0 | 0.2 | GO:0031117 | positive regulation of microtubule depolymerization(GO:0031117) |
0.0 | 0.4 | GO:0007598 | blood coagulation, extrinsic pathway(GO:0007598) |
0.0 | 0.2 | GO:0051563 | smooth endoplasmic reticulum calcium ion homeostasis(GO:0051563) |
0.0 | 0.2 | GO:0072679 | positive regulation of sperm motility involved in capacitation(GO:0060474) thymocyte migration(GO:0072679) |
0.0 | 0.1 | GO:0030505 | inorganic diphosphate transport(GO:0030505) |
0.0 | 0.2 | GO:0034445 | regulation of plasma lipoprotein particle oxidation(GO:0034444) negative regulation of plasma lipoprotein particle oxidation(GO:0034445) |
0.0 | 0.3 | GO:2000402 | negative regulation of lymphocyte migration(GO:2000402) |
0.0 | 0.3 | GO:0002578 | negative regulation of antigen processing and presentation(GO:0002578) |
0.0 | 0.1 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
0.0 | 0.6 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
0.0 | 0.7 | GO:1902224 | ketone body metabolic process(GO:1902224) |
0.0 | 0.2 | GO:0061763 | multivesicular body-lysosome fusion(GO:0061763) |
0.0 | 0.1 | GO:0071393 | cellular response to progesterone stimulus(GO:0071393) |
0.0 | 1.0 | GO:0006346 | methylation-dependent chromatin silencing(GO:0006346) |
0.0 | 0.1 | GO:0044278 | cell wall disruption in other organism(GO:0044278) |
0.0 | 0.2 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.0 | 0.3 | GO:0033183 | negative regulation of histone ubiquitination(GO:0033183) regulation of histone H2A K63-linked ubiquitination(GO:1901314) negative regulation of histone H2A K63-linked ubiquitination(GO:1901315) |
0.0 | 0.3 | GO:1903265 | positive regulation of tumor necrosis factor-mediated signaling pathway(GO:1903265) |
0.0 | 0.1 | GO:1901420 | negative regulation of vitamin D receptor signaling pathway(GO:0070563) negative regulation of response to alcohol(GO:1901420) |
0.0 | 1.5 | GO:0015721 | bile acid and bile salt transport(GO:0015721) |
0.0 | 0.4 | GO:0032071 | regulation of endodeoxyribonuclease activity(GO:0032071) |
0.0 | 0.3 | GO:0034351 | regulation of glial cell apoptotic process(GO:0034350) negative regulation of glial cell apoptotic process(GO:0034351) |
0.0 | 0.1 | GO:0034473 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) |
0.0 | 0.1 | GO:0002859 | tolerance induction dependent upon immune response(GO:0002461) regulation of tolerance induction dependent upon immune response(GO:0002652) negative regulation of response to tumor cell(GO:0002835) negative regulation of immune response to tumor cell(GO:0002838) negative regulation of natural killer cell mediated immune response to tumor cell(GO:0002856) negative regulation of natural killer cell mediated cytotoxicity directed against tumor cell target(GO:0002859) |
0.0 | 0.2 | GO:0001705 | ectoderm formation(GO:0001705) ectodermal cell fate commitment(GO:0001712) |
0.0 | 0.4 | GO:0007249 | I-kappaB kinase/NF-kappaB signaling(GO:0007249) |
0.0 | 0.6 | GO:0030854 | positive regulation of granulocyte differentiation(GO:0030854) |
0.0 | 0.5 | GO:0006564 | L-serine biosynthetic process(GO:0006564) |
0.0 | 0.4 | GO:1901409 | positive regulation of phosphorylation of RNA polymerase II C-terminal domain(GO:1901409) |
0.0 | 0.4 | GO:0048387 | negative regulation of retinoic acid receptor signaling pathway(GO:0048387) |
0.0 | 0.2 | GO:0071461 | cellular response to redox state(GO:0071461) |
0.0 | 0.3 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 0.2 | GO:0046070 | dGTP metabolic process(GO:0046070) |
0.0 | 0.9 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.0 | 0.3 | GO:0050859 | negative regulation of B cell receptor signaling pathway(GO:0050859) |
0.0 | 1.0 | GO:0042744 | hydrogen peroxide catabolic process(GO:0042744) |
0.0 | 0.1 | GO:0072086 | specification of loop of Henle identity(GO:0072086) pattern specification involved in metanephros development(GO:0072268) |
0.0 | 0.4 | GO:0051639 | actin filament network formation(GO:0051639) |
0.0 | 0.4 | GO:0048842 | positive regulation of axon extension involved in axon guidance(GO:0048842) |
0.0 | 0.1 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.0 | 0.1 | GO:0071484 | cellular response to light intensity(GO:0071484) |
0.0 | 0.8 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.0 | 0.1 | GO:0032661 | regulation of interleukin-18 production(GO:0032661) |
0.0 | 0.2 | GO:0010637 | negative regulation of mitochondrial fusion(GO:0010637) |
0.0 | 0.2 | GO:0086068 | Purkinje myocyte to ventricular cardiac muscle cell signaling(GO:0086029) Purkinje myocyte to ventricular cardiac muscle cell communication(GO:0086068) |
0.0 | 0.2 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
0.0 | 0.2 | GO:0097475 | motor neuron migration(GO:0097475) |
0.0 | 0.1 | GO:0003406 | retinal pigment epithelium development(GO:0003406) |
0.0 | 0.1 | GO:1904158 | axonemal central apparatus assembly(GO:1904158) |
0.0 | 0.9 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
0.0 | 0.1 | GO:0001970 | positive regulation of activation of membrane attack complex(GO:0001970) |
0.0 | 0.5 | GO:0010002 | cardioblast differentiation(GO:0010002) |
0.0 | 0.1 | GO:1904796 | regulation of core promoter binding(GO:1904796) positive regulation of core promoter binding(GO:1904798) |
0.0 | 0.1 | GO:0098759 | response to interleukin-8(GO:0098758) cellular response to interleukin-8(GO:0098759) |
0.0 | 0.1 | GO:2000508 | regulation of dendritic cell chemotaxis(GO:2000508) |
0.0 | 0.2 | GO:0010248 | establishment or maintenance of transmembrane electrochemical gradient(GO:0010248) |
0.0 | 0.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
0.0 | 0.1 | GO:0007386 | compartment pattern specification(GO:0007386) |
0.0 | 0.1 | GO:0031508 | pericentric heterochromatin assembly(GO:0031508) |
0.0 | 0.4 | GO:0006703 | estrogen biosynthetic process(GO:0006703) |
0.0 | 2.6 | GO:0050911 | detection of chemical stimulus involved in sensory perception of smell(GO:0050911) |
0.0 | 0.9 | GO:0042730 | fibrinolysis(GO:0042730) |
0.0 | 0.5 | GO:0043248 | proteasome assembly(GO:0043248) |
0.0 | 0.1 | GO:0097460 | ferrous iron import into cell(GO:0097460) ferrous iron import across plasma membrane(GO:0098707) |
0.0 | 0.1 | GO:0032416 | negative regulation of sodium:proton antiporter activity(GO:0032416) |
0.0 | 0.1 | GO:0008063 | Toll signaling pathway(GO:0008063) |
0.0 | 0.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
0.0 | 0.1 | GO:0071866 | regulation of apoptotic process in bone marrow(GO:0071865) negative regulation of apoptotic process in bone marrow(GO:0071866) positive regulation of osteoclast proliferation(GO:0090290) negative regulation of bone mineralization involved in bone maturation(GO:1900158) |
0.0 | 2.4 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
0.0 | 0.1 | GO:1902683 | regulation of receptor localization to synapse(GO:1902683) |
0.0 | 0.1 | GO:1901491 | negative regulation of lymphangiogenesis(GO:1901491) |
0.0 | 1.3 | GO:0050690 | regulation of defense response to virus by virus(GO:0050690) |
0.0 | 0.1 | GO:0045819 | positive regulation of glycogen catabolic process(GO:0045819) |
0.0 | 0.5 | GO:1901642 | nucleoside transmembrane transport(GO:1901642) |
0.0 | 0.1 | GO:1904381 | Golgi apparatus mannose trimming(GO:1904381) |
0.0 | 0.1 | GO:0046586 | regulation of calcium-dependent cell-cell adhesion(GO:0046586) |
0.0 | 0.1 | GO:0000821 | regulation of arginine metabolic process(GO:0000821) |
0.0 | 0.3 | GO:0070587 | negative regulation of heterotypic cell-cell adhesion(GO:0034115) regulation of cell-cell adhesion involved in gastrulation(GO:0070587) |
0.0 | 0.2 | GO:0045359 | positive regulation of interferon-beta biosynthetic process(GO:0045359) |
0.0 | 0.2 | GO:0002726 | positive regulation of T cell cytokine production(GO:0002726) |
0.0 | 0.1 | GO:1990258 | box C/D snoRNA 3'-end processing(GO:0000494) box C/D snoRNA metabolic process(GO:0033967) box C/D snoRNA processing(GO:0034963) histone glutamine methylation(GO:1990258) |
0.0 | 0.3 | GO:0045329 | carnitine biosynthetic process(GO:0045329) |
0.0 | 0.0 | GO:0014738 | regulation of muscle hyperplasia(GO:0014738) |
0.0 | 3.1 | GO:0030449 | regulation of complement activation(GO:0030449) |
0.0 | 0.1 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
0.0 | 0.3 | GO:0007008 | outer mitochondrial membrane organization(GO:0007008) |
0.0 | 0.3 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
0.0 | 0.0 | GO:2001183 | negative regulation of interleukin-12 secretion(GO:2001183) |
0.0 | 0.2 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
0.0 | 0.2 | GO:2000535 | regulation of entry of bacterium into host cell(GO:2000535) |
0.0 | 0.1 | GO:0019065 | receptor-mediated endocytosis of virus by host cell(GO:0019065) endocytosis involved in viral entry into host cell(GO:0075509) |
0.0 | 0.2 | GO:0042866 | pyruvate biosynthetic process(GO:0042866) |
0.0 | 0.3 | GO:0006122 | mitochondrial electron transport, ubiquinol to cytochrome c(GO:0006122) |
0.0 | 0.1 | GO:0070898 | RNA polymerase III transcriptional preinitiation complex assembly(GO:0070898) |
0.0 | 0.2 | GO:0043383 | negative T cell selection(GO:0043383) |
0.0 | 0.1 | GO:0014835 | myoblast differentiation involved in skeletal muscle regeneration(GO:0014835) |
0.0 | 0.2 | GO:0046541 | saliva secretion(GO:0046541) |
0.0 | 0.2 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.0 | 0.4 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.0 | 0.1 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.0 | 0.0 | GO:1904760 | myofibroblast differentiation(GO:0036446) regulation of myofibroblast differentiation(GO:1904760) |
0.0 | 0.2 | GO:0048003 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
0.0 | 0.1 | GO:0032526 | response to retinoic acid(GO:0032526) |
0.0 | 0.2 | GO:0038007 | netrin-activated signaling pathway(GO:0038007) |
0.0 | 0.1 | GO:0015692 | lead ion transport(GO:0015692) |
0.0 | 0.1 | GO:0021766 | hippocampus development(GO:0021766) |
0.0 | 0.1 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.0 | 0.1 | GO:0090234 | regulation of kinetochore assembly(GO:0090234) |
0.0 | 0.2 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.0 | 0.1 | GO:1904751 | positive regulation of protein localization to nucleolus(GO:1904751) |
0.0 | 0.1 | GO:0086036 | regulation of cardiac muscle cell membrane potential(GO:0086036) |
0.0 | 0.4 | GO:0032461 | positive regulation of protein oligomerization(GO:0032461) |
0.0 | 0.3 | GO:0002097 | tRNA wobble base modification(GO:0002097) |
0.0 | 0.1 | GO:0033600 | cerebral cortex tangential migration using cell-cell interactions(GO:0021823) postnatal olfactory bulb interneuron migration(GO:0021827) chemorepulsion involved in postnatal olfactory bulb interneuron migration(GO:0021836) negative regulation of mammary gland epithelial cell proliferation(GO:0033600) |
0.0 | 0.1 | GO:0038043 | interleukin-5-mediated signaling pathway(GO:0038043) |
0.0 | 0.1 | GO:0010387 | COP9 signalosome assembly(GO:0010387) |
0.0 | 0.1 | GO:0050928 | negative regulation of positive chemotaxis(GO:0050928) |
0.0 | 0.7 | GO:1901685 | glutathione derivative metabolic process(GO:1901685) glutathione derivative biosynthetic process(GO:1901687) |
0.0 | 0.1 | GO:0019720 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) |
0.0 | 0.1 | GO:0038155 | interleukin-23-mediated signaling pathway(GO:0038155) |
0.0 | 0.1 | GO:0060368 | regulation of Fc receptor mediated stimulatory signaling pathway(GO:0060368) |
0.0 | 0.1 | GO:0061762 | CAMKK-AMPK signaling cascade(GO:0061762) |
0.0 | 0.6 | GO:0070286 | axonemal dynein complex assembly(GO:0070286) |
0.0 | 0.2 | GO:0086024 | adrenergic receptor signaling pathway involved in positive regulation of heart rate(GO:0086024) |
0.0 | 0.3 | GO:0014883 | transition between fast and slow fiber(GO:0014883) |
0.0 | 0.3 | GO:0072643 | interferon-gamma secretion(GO:0072643) |
0.0 | 0.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.0 | 1.8 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.0 | 0.1 | GO:1902459 | positive regulation of stem cell population maintenance(GO:1902459) |
0.0 | 0.2 | GO:0006600 | creatine metabolic process(GO:0006600) |
0.0 | 0.1 | GO:0043031 | negative regulation of macrophage activation(GO:0043031) |
0.0 | 0.0 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
0.0 | 0.1 | GO:0014038 | regulation of Schwann cell differentiation(GO:0014038) |
0.0 | 0.2 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
0.0 | 0.3 | GO:0006450 | regulation of translational fidelity(GO:0006450) |
0.0 | 0.5 | GO:0007635 | chemosensory behavior(GO:0007635) |
0.0 | 0.2 | GO:0060211 | regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060211) positive regulation of nuclear-transcribed mRNA poly(A) tail shortening(GO:0060213) |
0.0 | 0.1 | GO:0072513 | positive regulation of secondary heart field cardioblast proliferation(GO:0072513) |
0.0 | 0.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.0 | 0.5 | GO:0097503 | sialylation(GO:0097503) |
0.0 | 0.2 | GO:0006704 | glucocorticoid biosynthetic process(GO:0006704) |
0.0 | 0.1 | GO:0000395 | mRNA 5'-splice site recognition(GO:0000395) |
0.0 | 0.2 | GO:0051451 | myoblast migration(GO:0051451) |
0.0 | 0.1 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.0 | 0.0 | GO:1903487 | regulation of lactation(GO:1903487) |
0.0 | 0.3 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.0 | 0.1 | GO:0097264 | self proteolysis(GO:0097264) |
0.0 | 0.1 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.0 | 0.1 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
0.0 | 0.0 | GO:0035552 | oxidative single-stranded DNA demethylation(GO:0035552) |
0.0 | 0.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
0.0 | 0.1 | GO:0045876 | positive regulation of sister chromatid cohesion(GO:0045876) |
0.0 | 0.1 | GO:0010792 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) |
0.0 | 0.2 | GO:0008090 | retrograde axonal transport(GO:0008090) |
0.0 | 0.8 | GO:0042267 | natural killer cell mediated cytotoxicity(GO:0042267) |
0.0 | 0.1 | GO:0098989 | NMDA selective glutamate receptor signaling pathway(GO:0098989) |
0.0 | 0.9 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
0.0 | 0.2 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
0.0 | 0.1 | GO:0019375 | galactosylceramide biosynthetic process(GO:0006682) galactolipid biosynthetic process(GO:0019375) |
0.0 | 0.6 | GO:0048384 | retinoic acid receptor signaling pathway(GO:0048384) |
0.0 | 0.0 | GO:0031247 | actin rod assembly(GO:0031247) |
0.0 | 0.0 | GO:1900738 | positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.0 | 0.2 | GO:0018065 | protein-cofactor linkage(GO:0018065) |
0.0 | 0.4 | GO:0035428 | hexose transmembrane transport(GO:0035428) glucose transmembrane transport(GO:1904659) |
0.0 | 0.2 | GO:0060134 | prepulse inhibition(GO:0060134) |
0.0 | 0.1 | GO:0042738 | exogenous drug catabolic process(GO:0042738) |
0.0 | 0.7 | GO:0031424 | keratinization(GO:0031424) |
0.0 | 0.1 | GO:0006970 | response to osmotic stress(GO:0006970) |
0.0 | 0.1 | GO:0000389 | mRNA 3'-splice site recognition(GO:0000389) |
0.0 | 0.1 | GO:0046784 | viral mRNA export from host cell nucleus(GO:0046784) |
0.0 | 0.1 | GO:0048563 | post-embryonic organ morphogenesis(GO:0048563) |
0.0 | 0.0 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
0.0 | 0.2 | GO:0060766 | negative regulation of androgen receptor signaling pathway(GO:0060766) |
0.0 | 0.1 | GO:0035810 | positive regulation of urine volume(GO:0035810) |
0.0 | 0.1 | GO:0014067 | negative regulation of phosphatidylinositol 3-kinase signaling(GO:0014067) |
0.0 | 0.2 | GO:0042439 | ethanolamine-containing compound metabolic process(GO:0042439) |
0.0 | 0.0 | GO:0072429 | response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.0 | 0.1 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.2 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.0 | 0.1 | GO:0015801 | aromatic amino acid transport(GO:0015801) |
0.0 | 0.1 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.0 | 0.1 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.0 | 0.1 | GO:1902416 | positive regulation of mRNA binding(GO:1902416) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.3 | 0.3 | GO:0030496 | midbody(GO:0030496) |
0.2 | 0.8 | GO:1902937 | inward rectifier potassium channel complex(GO:1902937) |
0.1 | 0.4 | GO:0005953 | CAAX-protein geranylgeranyltransferase complex(GO:0005953) |
0.1 | 0.8 | GO:0030061 | mitochondrial crista(GO:0030061) |
0.1 | 1.7 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.1 | 0.8 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
0.1 | 5.4 | GO:0001533 | cornified envelope(GO:0001533) |
0.1 | 0.3 | GO:0005889 | hydrogen:potassium-exchanging ATPase complex(GO:0005889) |
0.1 | 0.7 | GO:0000801 | central element(GO:0000801) |
0.1 | 1.7 | GO:0031143 | pseudopodium(GO:0031143) |
0.1 | 0.2 | GO:0031673 | H zone(GO:0031673) |
0.1 | 0.1 | GO:0043159 | acrosomal matrix(GO:0043159) |
0.1 | 0.8 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
0.1 | 1.5 | GO:0032982 | myosin filament(GO:0032982) |
0.1 | 1.8 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
0.0 | 0.2 | GO:0071008 | U2-type post-mRNA release spliceosomal complex(GO:0071008) |
0.0 | 0.7 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
0.0 | 0.5 | GO:0045252 | oxoglutarate dehydrogenase complex(GO:0045252) |
0.0 | 0.1 | GO:1990716 | axonemal central apparatus(GO:1990716) |
0.0 | 0.1 | GO:0019008 | molybdopterin synthase complex(GO:0019008) |
0.0 | 0.5 | GO:0033269 | internode region of axon(GO:0033269) |
0.0 | 1.0 | GO:0042613 | MHC class II protein complex(GO:0042613) |
0.0 | 0.1 | GO:0005683 | U7 snRNP(GO:0005683) |
0.0 | 0.4 | GO:0008541 | proteasome regulatory particle, lid subcomplex(GO:0008541) |
0.0 | 0.2 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
0.0 | 0.1 | GO:0031379 | RNA-directed RNA polymerase complex(GO:0031379) |
0.0 | 0.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
0.0 | 1.2 | GO:0031231 | integral component of peroxisomal membrane(GO:0005779) intrinsic component of peroxisomal membrane(GO:0031231) |
0.0 | 3.5 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.0 | 0.6 | GO:0043020 | NADPH oxidase complex(GO:0043020) |
0.0 | 0.2 | GO:0097209 | epidermal lamellar body(GO:0097209) |
0.0 | 1.9 | GO:0030669 | clathrin-coated endocytic vesicle membrane(GO:0030669) |
0.0 | 0.3 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
0.0 | 0.4 | GO:0070652 | HAUS complex(GO:0070652) |
0.0 | 0.3 | GO:0071541 | eukaryotic translation initiation factor 3 complex, eIF3m(GO:0071541) |
0.0 | 0.4 | GO:0042622 | photoreceptor outer segment membrane(GO:0042622) |
0.0 | 0.1 | GO:0071149 | TEAD-2-YAP complex(GO:0071149) |
0.0 | 0.6 | GO:0005922 | connexon complex(GO:0005922) |
0.0 | 0.2 | GO:0043541 | UDP-N-acetylglucosamine transferase complex(GO:0043541) |
0.0 | 0.1 | GO:0036195 | muscle cell projection(GO:0036194) muscle cell projection membrane(GO:0036195) |
0.0 | 0.2 | GO:0030314 | junctional membrane complex(GO:0030314) |
0.0 | 0.1 | GO:0002139 | stereocilia coupling link(GO:0002139) |
0.0 | 0.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
0.0 | 1.0 | GO:0070069 | cytochrome complex(GO:0070069) |
0.0 | 0.1 | GO:0005899 | insulin receptor complex(GO:0005899) |
0.0 | 1.6 | GO:0031526 | brush border membrane(GO:0031526) |
0.0 | 2.2 | GO:0034707 | chloride channel complex(GO:0034707) |
0.0 | 0.0 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
0.0 | 0.1 | GO:0043202 | lysosomal lumen(GO:0043202) |
0.0 | 0.2 | GO:0005579 | membrane attack complex(GO:0005579) |
0.0 | 0.2 | GO:0043527 | tRNA methyltransferase complex(GO:0043527) |
0.0 | 0.5 | GO:0001891 | phagocytic cup(GO:0001891) |
0.0 | 0.2 | GO:1990812 | growth cone lamellipodium(GO:1990761) growth cone filopodium(GO:1990812) |
0.0 | 0.2 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.0 | 0.1 | GO:0035841 | new growing cell tip(GO:0035841) |
0.0 | 0.3 | GO:0001520 | outer dense fiber(GO:0001520) |
0.0 | 0.1 | GO:1990462 | omegasome(GO:1990462) |
0.0 | 0.1 | GO:0016939 | kinesin II complex(GO:0016939) |
0.0 | 1.4 | GO:0045095 | keratin filament(GO:0045095) |
0.0 | 0.1 | GO:0072536 | interleukin-23 receptor complex(GO:0072536) |
0.0 | 0.3 | GO:0034709 | methylosome(GO:0034709) |
0.0 | 0.2 | GO:0097524 | sperm plasma membrane(GO:0097524) |
0.0 | 0.7 | GO:0016592 | mediator complex(GO:0016592) |
0.0 | 0.8 | GO:0001772 | immunological synapse(GO:0001772) |
0.0 | 0.5 | GO:0031304 | intrinsic component of mitochondrial inner membrane(GO:0031304) integral component of mitochondrial inner membrane(GO:0031305) |
0.0 | 0.1 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.0 | 0.4 | GO:0097381 | photoreceptor disc membrane(GO:0097381) |
0.0 | 0.3 | GO:0034045 | pre-autophagosomal structure membrane(GO:0034045) |
0.0 | 0.1 | GO:0097125 | cyclin B1-CDK1 complex(GO:0097125) |
0.0 | 0.3 | GO:0005861 | troponin complex(GO:0005861) |
0.0 | 0.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
0.0 | 0.2 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.0 | 0.1 | GO:0000243 | commitment complex(GO:0000243) |
0.0 | 1.3 | GO:0070821 | tertiary granule membrane(GO:0070821) |
0.0 | 0.1 | GO:0000275 | mitochondrial proton-transporting ATP synthase complex, catalytic core F(1)(GO:0000275) |
0.0 | 0.2 | GO:0005859 | muscle myosin complex(GO:0005859) |
0.0 | 0.1 | GO:0005652 | nuclear lamina(GO:0005652) |
0.0 | 0.4 | GO:0030673 | axolemma(GO:0030673) |
0.0 | 0.1 | GO:0000408 | EKC/KEOPS complex(GO:0000408) |
0.0 | 0.1 | GO:0097550 | transcriptional preinitiation complex(GO:0097550) |
0.0 | 0.1 | GO:0005787 | signal peptidase complex(GO:0005787) |
0.0 | 0.1 | GO:0005927 | muscle tendon junction(GO:0005927) |
0.0 | 0.8 | GO:1903293 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.0 | 0.1 | GO:0030877 | beta-catenin destruction complex(GO:0030877) |
0.0 | 0.1 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.4 | 1.8 | GO:0060961 | phospholipase D inhibitor activity(GO:0060961) |
0.3 | 0.8 | GO:0004796 | thromboxane-A synthase activity(GO:0004796) 12-hydroxyheptadecatrienoic acid synthase activity(GO:0036134) |
0.2 | 1.2 | GO:0080019 | fatty-acyl-CoA reductase (alcohol-forming) activity(GO:0080019) |
0.2 | 2.6 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
0.2 | 0.6 | GO:0047086 | phenanthrene 9,10-monooxygenase activity(GO:0018636) ketosteroid monooxygenase activity(GO:0047086) |
0.2 | 0.4 | GO:0047006 | 17-alpha,20-alpha-dihydroxypregn-4-en-3-one dehydrogenase activity(GO:0047006) |
0.2 | 0.7 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
0.2 | 0.5 | GO:0051499 | D-aminoacyl-tRNA deacylase activity(GO:0051499) D-tyrosyl-tRNA(Tyr) deacylase activity(GO:0051500) |
0.2 | 0.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
0.1 | 0.4 | GO:0004662 | CAAX-protein geranylgeranyltransferase activity(GO:0004662) |
0.1 | 0.4 | GO:0004531 | deoxyribonuclease II activity(GO:0004531) |
0.1 | 0.6 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
0.1 | 3.8 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.1 | 0.7 | GO:0004105 | choline-phosphate cytidylyltransferase activity(GO:0004105) |
0.1 | 0.6 | GO:0042289 | MHC class II protein binding(GO:0042289) |
0.1 | 0.7 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
0.1 | 0.5 | GO:0052798 | beta-galactoside alpha-2,3-sialyltransferase activity(GO:0052798) |
0.1 | 0.7 | GO:0052828 | phosphatidylinositol-3,4-bisphosphate 4-phosphatase activity(GO:0016316) inositol-1,3,4-trisphosphate 4-phosphatase activity(GO:0017161) inositol-3,4-bisphosphate 4-phosphatase activity(GO:0052828) |
0.1 | 0.4 | GO:0008336 | gamma-butyrobetaine dioxygenase activity(GO:0008336) |
0.1 | 0.3 | GO:0005150 | interleukin-1, Type I receptor binding(GO:0005150) |
0.1 | 0.9 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.1 | 0.1 | GO:0004869 | cysteine-type endopeptidase inhibitor activity(GO:0004869) |
0.1 | 0.6 | GO:0015119 | hexose phosphate transmembrane transporter activity(GO:0015119) organophosphate:inorganic phosphate antiporter activity(GO:0015315) hexose-phosphate:inorganic phosphate antiporter activity(GO:0015526) glucose 6-phosphate:inorganic phosphate antiporter activity(GO:0061513) |
0.1 | 0.5 | GO:0004447 | iodide peroxidase activity(GO:0004447) |
0.1 | 0.5 | GO:0005499 | vitamin D binding(GO:0005499) |
0.1 | 0.3 | GO:0008745 | N-acetylmuramoyl-L-alanine amidase activity(GO:0008745) |
0.1 | 0.3 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 2.0 | GO:0001608 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
0.1 | 0.6 | GO:0008048 | calcium sensitive guanylate cyclase activator activity(GO:0008048) |
0.1 | 2.4 | GO:0098641 | cadherin binding involved in cell-cell adhesion(GO:0098641) |
0.1 | 0.2 | GO:0061135 | endopeptidase inhibitor activity(GO:0004866) endopeptidase regulator activity(GO:0061135) |
0.1 | 0.2 | GO:0031862 | prostanoid receptor binding(GO:0031862) |
0.1 | 0.5 | GO:0004591 | oxoglutarate dehydrogenase (succinyl-transferring) activity(GO:0004591) |
0.1 | 0.5 | GO:0050682 | AF-2 domain binding(GO:0050682) |
0.1 | 0.2 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
0.1 | 2.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.1 | 1.9 | GO:0031489 | myosin V binding(GO:0031489) |
0.1 | 0.3 | GO:0004699 | calcium-independent protein kinase C activity(GO:0004699) |
0.1 | 0.2 | GO:0015928 | alpha-L-fucosidase activity(GO:0004560) fucosidase activity(GO:0015928) |
0.1 | 0.6 | GO:0005025 | transforming growth factor beta receptor activity, type I(GO:0005025) |
0.1 | 1.3 | GO:0015125 | bile acid transmembrane transporter activity(GO:0015125) |
0.1 | 0.2 | GO:0017082 | mineralocorticoid receptor activity(GO:0017082) |
0.1 | 0.4 | GO:0004647 | phosphoserine phosphatase activity(GO:0004647) |
0.1 | 0.5 | GO:0004064 | arylesterase activity(GO:0004064) |
0.1 | 0.2 | GO:0000773 | phosphatidyl-N-methylethanolamine N-methyltransferase activity(GO:0000773) phosphatidylethanolamine N-methyltransferase activity(GO:0004608) phosphatidyl-N-dimethylethanolamine N-methyltransferase activity(GO:0080101) |
0.1 | 0.2 | GO:0046848 | hydroxyapatite binding(GO:0046848) |
0.1 | 0.2 | GO:0003845 | 11-beta-hydroxysteroid dehydrogenase [NAD(P)] activity(GO:0003845) |
0.1 | 0.3 | GO:0035529 | NADH pyrophosphatase activity(GO:0035529) |
0.1 | 1.1 | GO:0050700 | CARD domain binding(GO:0050700) |
0.1 | 0.3 | GO:0004692 | cGMP-dependent protein kinase activity(GO:0004692) |
0.1 | 0.2 | GO:0097677 | STAT family protein binding(GO:0097677) |
0.1 | 0.6 | GO:0071253 | connexin binding(GO:0071253) |
0.1 | 0.4 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
0.1 | 0.2 | GO:0086062 | voltage-gated sodium channel activity involved in Purkinje myocyte action potential(GO:0086062) |
0.1 | 0.7 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.1 | 7.3 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.1 | 0.2 | GO:0035379 | carbon dioxide transmembrane transporter activity(GO:0035379) |
0.1 | 0.7 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.0 | 1.4 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.0 | 0.6 | GO:0001011 | transcription factor activity, sequence-specific DNA binding, RNA polymerase recruiting(GO:0001011) transcription factor activity, TFIIB-class binding(GO:0001087) |
0.0 | 1.2 | GO:0008239 | dipeptidyl-peptidase activity(GO:0008239) |
0.0 | 0.1 | GO:0061599 | molybdopterin adenylyltransferase activity(GO:0061598) molybdopterin molybdotransferase activity(GO:0061599) |
0.0 | 0.1 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
0.0 | 0.2 | GO:0004815 | aspartate-tRNA ligase activity(GO:0004815) |
0.0 | 0.1 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.0 | 0.2 | GO:0070728 | leucine binding(GO:0070728) |
0.0 | 0.2 | GO:0050509 | N-acetylglucosaminyl-proteoglycan 4-beta-glucuronosyltransferase activity(GO:0050509) |
0.0 | 0.5 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.0 | 0.6 | GO:0043236 | laminin binding(GO:0043236) |
0.0 | 0.2 | GO:0004886 | 9-cis retinoic acid receptor activity(GO:0004886) vitamin D response element binding(GO:0070644) |
0.0 | 0.2 | GO:0016623 | aldehyde oxidase activity(GO:0004031) oxidoreductase activity, acting on the aldehyde or oxo group of donors, oxygen as acceptor(GO:0016623) |
0.0 | 0.4 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
0.0 | 1.0 | GO:0070330 | aromatase activity(GO:0070330) |
0.0 | 0.1 | GO:0030627 | pre-mRNA 5'-splice site binding(GO:0030627) |
0.0 | 1.1 | GO:0002162 | dystroglycan binding(GO:0002162) |
0.0 | 0.4 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.0 | 0.3 | GO:1901612 | cardiolipin binding(GO:1901612) |
0.0 | 0.3 | GO:0016681 | ubiquinol-cytochrome-c reductase activity(GO:0008121) oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) oxidoreductase activity, acting on diphenols and related substances as donors, cytochrome as acceptor(GO:0016681) |
0.0 | 1.5 | GO:0001972 | retinoic acid binding(GO:0001972) |
0.0 | 0.4 | GO:0005176 | ErbB-2 class receptor binding(GO:0005176) |
0.0 | 0.4 | GO:0047623 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
0.0 | 0.8 | GO:0022841 | potassium ion leak channel activity(GO:0022841) |
0.0 | 0.5 | GO:0032395 | MHC class II receptor activity(GO:0032395) |
0.0 | 0.9 | GO:0004707 | MAP kinase activity(GO:0004707) |
0.0 | 0.1 | GO:0019862 | IgA binding(GO:0019862) |
0.0 | 0.4 | GO:0019534 | toxin transporter activity(GO:0019534) |
0.0 | 0.2 | GO:0015186 | L-glutamine transmembrane transporter activity(GO:0015186) |
0.0 | 2.3 | GO:0017080 | sodium channel regulator activity(GO:0017080) |
0.0 | 0.0 | GO:0016715 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced ascorbate as one donor, and incorporation of one atom of oxygen(GO:0016715) |
0.0 | 0.1 | GO:0047275 | glucosaminylgalactosylglucosylceramide beta-galactosyltransferase activity(GO:0047275) |
0.0 | 0.3 | GO:0004111 | creatine kinase activity(GO:0004111) |
0.0 | 0.1 | GO:0008124 | 4-alpha-hydroxytetrahydrobiopterin dehydratase activity(GO:0008124) |
0.0 | 0.1 | GO:0072510 | ferric iron transmembrane transporter activity(GO:0015091) trivalent inorganic cation transmembrane transporter activity(GO:0072510) |
0.0 | 0.5 | GO:0045236 | CXCR chemokine receptor binding(GO:0045236) |
0.0 | 0.5 | GO:0005549 | odorant binding(GO:0005549) |
0.0 | 0.6 | GO:0016175 | superoxide-generating NADPH oxidase activity(GO:0016175) |
0.0 | 0.1 | GO:0008900 | hydrogen:potassium-exchanging ATPase activity(GO:0008900) |
0.0 | 0.2 | GO:0045174 | oxidoreductase activity, acting on a sulfur group of donors, quinone or similar compound as acceptor(GO:0016672) glutathione dehydrogenase (ascorbate) activity(GO:0045174) methylarsonate reductase activity(GO:0050610) |
0.0 | 0.1 | GO:0001034 | RNA polymerase III transcription factor activity, sequence-specific DNA binding(GO:0001034) |
0.0 | 0.6 | GO:0017049 | GTP-Rho binding(GO:0017049) |
0.0 | 0.1 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.0 | 0.1 | GO:0004743 | pyruvate kinase activity(GO:0004743) |
0.0 | 0.7 | GO:0017127 | cholesterol transporter activity(GO:0017127) |
0.0 | 0.3 | GO:0031433 | telethonin binding(GO:0031433) |
0.0 | 0.5 | GO:0019911 | structural constituent of myelin sheath(GO:0019911) |
0.0 | 0.2 | GO:0005250 | A-type (transient outward) potassium channel activity(GO:0005250) |
0.0 | 0.3 | GO:0015266 | protein channel activity(GO:0015266) |
0.0 | 0.2 | GO:0008079 | translation release factor activity(GO:0003747) translation termination factor activity(GO:0008079) |
0.0 | 0.1 | GO:0019959 | interleukin-8 binding(GO:0019959) |
0.0 | 0.1 | GO:0019239 | deaminase activity(GO:0019239) |
0.0 | 0.3 | GO:0045159 | myosin II binding(GO:0045159) |
0.0 | 0.1 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
0.0 | 0.4 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.0 | 0.4 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0030492 | hemoglobin binding(GO:0030492) |
0.0 | 2.1 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.0 | 0.3 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.0 | 0.1 | GO:1902122 | chenodeoxycholic acid binding(GO:1902122) |
0.0 | 0.1 | GO:1990259 | protein-glutamine N-methyltransferase activity(GO:0036009) histone-glutamine methyltransferase activity(GO:1990259) |
0.0 | 0.2 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.0 | 0.2 | GO:0016721 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
0.0 | 0.2 | GO:0030884 | lipid antigen binding(GO:0030882) endogenous lipid antigen binding(GO:0030883) exogenous lipid antigen binding(GO:0030884) |
0.0 | 0.1 | GO:0044729 | hemi-methylated DNA-binding(GO:0044729) |
0.0 | 0.2 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.0 | 0.6 | GO:0034237 | protein kinase A regulatory subunit binding(GO:0034237) |
0.0 | 0.1 | GO:0071209 | U7 snRNA binding(GO:0071209) |
0.0 | 0.1 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.0 | 0.3 | GO:0004000 | adenosine deaminase activity(GO:0004000) |
0.0 | 0.2 | GO:0005094 | Rho GDP-dissociation inhibitor activity(GO:0005094) |
0.0 | 0.1 | GO:0015086 | cadmium ion transmembrane transporter activity(GO:0015086) cobalt ion transmembrane transporter activity(GO:0015087) lead ion transmembrane transporter activity(GO:0015094) ferrous iron uptake transmembrane transporter activity(GO:0015639) |
0.0 | 0.0 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
0.0 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.0 | 0.1 | GO:0004914 | interleukin-5 receptor activity(GO:0004914) |
0.0 | 0.1 | GO:0042806 | fucose binding(GO:0042806) |
0.0 | 0.2 | GO:0016724 | ferroxidase activity(GO:0004322) oxidoreductase activity, oxidizing metal ions, oxygen as acceptor(GO:0016724) |
0.0 | 0.1 | GO:0004382 | guanosine-diphosphatase activity(GO:0004382) |
0.0 | 0.1 | GO:0042019 | interleukin-23 binding(GO:0042019) interleukin-23 receptor activity(GO:0042020) |
0.0 | 0.3 | GO:0016274 | arginine N-methyltransferase activity(GO:0016273) protein-arginine N-methyltransferase activity(GO:0016274) |
0.0 | 0.3 | GO:0009982 | pseudouridine synthase activity(GO:0009982) |
0.0 | 0.3 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
0.0 | 0.5 | GO:0019706 | protein-cysteine S-palmitoyltransferase activity(GO:0019706) protein-cysteine S-acyltransferase activity(GO:0019707) |
0.0 | 0.4 | GO:0016805 | dipeptidase activity(GO:0016805) |
0.0 | 0.6 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
0.0 | 0.2 | GO:0019957 | C-C chemokine binding(GO:0019957) |
0.0 | 0.1 | GO:0047820 | D-glutamate cyclase activity(GO:0047820) |
0.0 | 0.1 | GO:0008467 | [heparan sulfate]-glucosamine 3-sulfotransferase 1 activity(GO:0008467) |
0.0 | 0.5 | GO:0005246 | calcium channel regulator activity(GO:0005246) |
0.0 | 0.1 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.0 | 0.1 | GO:0047685 | amine sulfotransferase activity(GO:0047685) |
0.0 | 0.1 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
0.0 | 0.5 | GO:0005337 | nucleoside transmembrane transporter activity(GO:0005337) |
0.0 | 0.2 | GO:0016423 | tRNA (guanine) methyltransferase activity(GO:0016423) |
0.0 | 0.0 | GO:1990404 | protein ADP-ribosylase activity(GO:1990404) |
0.0 | 0.2 | GO:0004859 | phospholipase inhibitor activity(GO:0004859) |
0.0 | 0.1 | GO:0001162 | RNA polymerase II intronic transcription regulatory region sequence-specific DNA binding(GO:0001162) |
0.0 | 0.1 | GO:0070290 | phospholipase D activity(GO:0004630) N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
0.0 | 0.4 | GO:0042605 | peptide antigen binding(GO:0042605) |
0.0 | 0.4 | GO:0003746 | translation elongation factor activity(GO:0003746) |
0.0 | 0.2 | GO:0008432 | JUN kinase binding(GO:0008432) |
0.0 | 0.9 | GO:0005507 | copper ion binding(GO:0005507) |
0.0 | 0.6 | GO:0004364 | glutathione transferase activity(GO:0004364) |
0.0 | 0.0 | GO:0004087 | carbamoyl-phosphate synthase (ammonia) activity(GO:0004087) carbamoyl-phosphate synthase (glutamine-hydrolyzing) activity(GO:0004088) |
0.0 | 0.1 | GO:0004925 | prolactin receptor activity(GO:0004925) |
0.0 | 0.2 | GO:0030215 | semaphorin receptor binding(GO:0030215) |
0.0 | 0.0 | GO:0004802 | transketolase activity(GO:0004802) |
0.0 | 0.1 | GO:0042834 | peptidoglycan binding(GO:0042834) |
0.0 | 0.1 | GO:0001517 | N-acetylglucosamine 6-O-sulfotransferase activity(GO:0001517) |
0.0 | 0.2 | GO:0008494 | translation activator activity(GO:0008494) |
0.0 | 0.1 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.0 | 0.3 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
0.0 | 0.1 | GO:0030060 | L-malate dehydrogenase activity(GO:0030060) |
0.0 | 0.1 | GO:0004652 | polynucleotide adenylyltransferase activity(GO:0004652) |
0.0 | 0.1 | GO:0022833 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
0.0 | 0.4 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.0 | 0.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.0 | 0.0 | GO:0031727 | CCR2 chemokine receptor binding(GO:0031727) |
0.0 | 0.2 | GO:0042974 | retinoic acid receptor binding(GO:0042974) |
0.0 | 0.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.0 | 0.8 | GO:0005044 | scavenger receptor activity(GO:0005044) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.0 | 0.9 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.0 | 0.4 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
0.0 | 0.8 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
0.0 | 1.6 | PID ERBB4 PATHWAY | ErbB4 signaling events |
0.0 | 6.9 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.0 | 1.5 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.0 | 0.5 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
0.0 | 1.0 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.0 | 0.5 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.0 | 0.8 | PID IL23 PATHWAY | IL23-mediated signaling events |
0.0 | 0.5 | ST B CELL ANTIGEN RECEPTOR | B Cell Antigen Receptor |
0.0 | 0.2 | PID RANBP2 PATHWAY | Sumoylation by RanBP2 regulates transcriptional repression |
0.0 | 0.3 | ST GA12 PATHWAY | G alpha 12 Pathway |
0.0 | 0.3 | PID IL1 PATHWAY | IL1-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
0.1 | 3.6 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
0.1 | 1.3 | REACTOME NEF MEDIATED DOWNREGULATION OF MHC CLASS I COMPLEX CELL SURFACE EXPRESSION | Genes involved in Nef mediated downregulation of MHC class I complex cell surface expression |
0.1 | 1.3 | REACTOME DSCAM INTERACTIONS | Genes involved in DSCAM interactions |
0.1 | 1.0 | REACTOME RECYCLING OF BILE ACIDS AND SALTS | Genes involved in Recycling of bile acids and salts |
0.1 | 1.6 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.1 | 0.8 | REACTOME TANDEM PORE DOMAIN POTASSIUM CHANNELS | Genes involved in Tandem pore domain potassium channels |
0.0 | 1.7 | REACTOME ENDOSOMAL SORTING COMPLEX REQUIRED FOR TRANSPORT ESCRT | Genes involved in Endosomal Sorting Complex Required For Transport (ESCRT) |
0.0 | 1.1 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.0 | 0.4 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 24 HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 24-hydroxycholesterol |
0.0 | 3.5 | REACTOME AMYLOIDS | Genes involved in Amyloids |
0.0 | 0.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.0 | 0.7 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
0.0 | 0.7 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
0.0 | 0.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
0.0 | 0.1 | REACTOME IRAK1 RECRUITS IKK COMPLEX | Genes involved in IRAK1 recruits IKK complex |
0.0 | 3.3 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
0.0 | 0.8 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
0.0 | 0.7 | REACTOME GAP JUNCTION ASSEMBLY | Genes involved in Gap junction assembly |
0.0 | 1.3 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
0.0 | 1.2 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.0 | 0.9 | REACTOME SYNTHESIS OF PC | Genes involved in Synthesis of PC |
0.0 | 2.0 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
0.0 | 0.2 | REACTOME TRAF6 MEDIATED INDUCTION OF TAK1 COMPLEX | Genes involved in TRAF6 mediated induction of TAK1 complex |
0.0 | 0.6 | REACTOME MYOGENESIS | Genes involved in Myogenesis |
0.0 | 2.2 | REACTOME OLFACTORY SIGNALING PATHWAY | Genes involved in Olfactory Signaling Pathway |
0.0 | 0.4 | REACTOME REVERSIBLE HYDRATION OF CARBON DIOXIDE | Genes involved in Reversible Hydration of Carbon Dioxide |
0.0 | 0.3 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.0 | 0.6 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
0.0 | 0.4 | REACTOME TAK1 ACTIVATES NFKB BY PHOSPHORYLATION AND ACTIVATION OF IKKS COMPLEX | Genes involved in TAK1 activates NFkB by phosphorylation and activation of IKKs complex |
0.0 | 0.7 | REACTOME SHC1 EVENTS IN ERBB4 SIGNALING | Genes involved in SHC1 events in ERBB4 signaling |
0.0 | 0.9 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.0 | 0.5 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
0.0 | 0.9 | REACTOME CYTOCHROME P450 ARRANGED BY SUBSTRATE TYPE | Genes involved in Cytochrome P450 - arranged by substrate type |
0.0 | 0.4 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
0.0 | 0.4 | REACTOME PRE NOTCH PROCESSING IN GOLGI | Genes involved in Pre-NOTCH Processing in Golgi |
0.0 | 0.7 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.0 | 0.1 | REACTOME TRANSPORT OF MATURE MRNA DERIVED FROM AN INTRONLESS TRANSCRIPT | Genes involved in Transport of Mature mRNA Derived from an Intronless Transcript |
0.0 | 0.1 | REACTOME REGULATION OF THE FANCONI ANEMIA PATHWAY | Genes involved in Regulation of the Fanconi anemia pathway |
0.0 | 0.4 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
0.0 | 0.3 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
0.0 | 0.6 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.0 | 1.5 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.5 | REACTOME TRANSPORT OF VITAMINS NUCLEOSIDES AND RELATED MOLECULES | Genes involved in Transport of vitamins, nucleosides, and related molecules |
0.0 | 0.4 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.0 | 0.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
0.0 | 0.1 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
0.0 | 0.1 | REACTOME SIGNALING BY FGFR3 MUTANTS | Genes involved in Signaling by FGFR3 mutants |